Publications

Detailed Information

The role of PET/CT for evaluating breast cancer

DC Field Value Language
dc.contributor.authorYang, Sang Kyu-
dc.contributor.authorCho, Nariya-
dc.contributor.authorMoon, Woo Kyung-
dc.date.accessioned2009-11-26T07:24:26Z-
dc.date.available2009-11-26T07:24:26Z-
dc.date.issued2007-10-10-
dc.identifier.citationKorean J Radiol 2007;8:429-437en
dc.identifier.issn1229-6929 (Print)-
dc.identifier.issn2005-8330 (Electronic)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17923786-
dc.identifier.urihttps://hdl.handle.net/10371/16108-
dc.description.abstractPositron emission tomography combined with computed tomography (PET/CT) has been receiving increasing attention during the recent years for making the diagnosis, for determining the staging and for the follow-up of various malignancies. The PET/CT findings of 58 breast cancer patients (age range: 34-79 years old, mean age: 50 years) were retrospectively compared with the PET or CT scans alone. PET/CT was found to be better than PET or CT alone for detecting small tumors or multiple metastases, for accurately localizing lymph node metastasis and for monitoring the response to chemotherapy in breast cancer patients.en
dc.language.isoenen
dc.publisherKorean Society of Radiologyen
dc.titleThe role of PET/CT for evaluating breast canceren
dc.typeArticleen
dc.contributor.AlternativeAuthor양상규-
dc.contributor.AlternativeAuthor조나리야-
dc.contributor.AlternativeAuthor문우경-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share